German researchers have developed CAR-T therapy for autoimmune disorders such as lupus, multiple sclerosis, and rheumatoid arthritis. The therapy involves modifying a patient’s T cells in a lab to better target disease. The therapy has shown positive results in clinical trials, with patients experiencing a reduction or elimination of symptoms. Experts are cautiously optimistic but acknowledge the need for longer-term follow-up and more research. There is also uncertainty about the therapy’s long-term effects, but it represents a hopeful advancement in treating these challenging diseases. The therapy may offer a potential cure, providing patients with an incredible break from their disease.
Source link
Study fuels hope CAR-T cell therapy could treat autoimmune disease
